Case Study: a global pharmaceuticals network organisation achieves complete data visibility and reduced breach risk with Exonar Reveal

Pharmaceuticals Company achieves 500% ROI with Exonar

The customer, a pharmaceuticals company, faced a significant data breach risk due to its vast amount of unstructured data spread across emails, hard drives, and an enterprise vault. With a large remote workforce, manually locating sensitive information and corporate intellectual property was slow and ineffective. To address this challenge, the company turned to the vendor Exonar and its data discovery product, Exonar Reveal.

Using Exonar Reveal, the pharmaceuticals company extracted and indexed its data, discovering 235 million items and identifying 18 million containing sensitive PII. The solution provided complete visibility, enabling data classification, deletion, and migration at scale. Exonar's platform integrated with Azure Information Protection and Office 365 to enable automated governance. The results included identifying £1.9 million in risk, achieving a 500% ROI, and realizing millions in efficiency savings from accurately finding valuable patent information.